NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of NantHealth, Inc. (NASDAQ:NH) resulting from allegations that NantHealth may have issued materially misleading business information to the investing public.
On March 6, 2017, health and medicine publication STAT published an article asserting that NantHealth founder Patrick Soon-Shiong donated $12 million to the University of Utah from three different tax-exempt entities he controlled, but $10 million of his donation would be funneled back to one of his companies. STAT also alleges that this scheme allowed NantHealth to inflate the number of test orders it reported to investors. On this news, shares of NantHealth fell sharply during intraday trading on March 6, 2017.
Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by NantHealth investors. If you purchased shares of NantHealth on or before March 3, 2017, please visit the firm’s website at http://www.rosenlegal.com/cases-1074.html for more information. You may also contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or kchan@rosenlegal.com.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Attorney Advertising. Prior results do not guarantee a similar outcome.
